Innovating chemistry

Philochem is a Swiss subsidiary of the Philogen group, acting as discovery center with a focus on chemical pharmaceutical products and technologies. Philochem also offers its encoded library technologies to discover small molecule-, peptide-, and antibody-binders to collaboration partners.

Oct 15 2024
, ,

Philogen to attend the European Association of Nuclear Medicine (EANM) annual meeting on October 19-23, 2024

Andrea Galbiati is giving a presentation about Philochem’s FAP-targeted radioligand therapeutics on October 20 (session 604), entitled “Development of Multivalent...
Aug 21 2024
, ,

Philochem to attend the Festival of Biologics 2024 in Basel (15-17 October 2024)

Dr. Andrea Galbiati will give a talk entitled "Small Molecule Therapeutics targeting Fibroblast Activation Protein in the tumor microenvironment” Dr. Ettore Gilardoni...
Jul 16 2024
, ,

Philochem to attend the 23rd Human Proteome Organization World Congress as presenting authors on October 20-24, 2024 in Dresden, Germany)

Philochem will participate at the 23rd HUPO Congress in October, presenting two posters: Domenico Ravazza (3rd year Ph.D. student): Mass spectrometry as a quantitative...
Nov 13 2022
,

Philogen to attend the TIDES Europe 2022 in Vienna, Austria (16-18 November)

Philogen will attend the TIDES Europe in Vienna in November 2022. Samuele Cazzamalli, Head of Small Molecules Therapeutics at Philogen, will give a lecture entitled...
Mar 15 2022

Philogen to attend the PEGS Europe 2022 on November 14-16, 2022

Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “Antibody-cytokine fusions: emerging clinical data in glioblastoma, sarcoma and dermato-oncology...

OUR SCIENCES

Learn about our strategy

PIPELINE

Learn more about our pipeline

WORK WITH US

Look at open positions